Lorenz von Seidlein, MD, was born in Germany and attended medical school in Dublin, Ireland. He completed a pediatric residency in Miami, an infectious disease fellowship at the University of California, Los Angeles, and a PhD in epidemiology from the London School of Tropical Medicine and Hygiene. From 2000 through 2010, Lorenz worked with the International Vaccine Institute in Seoul, Korea, where he managed several large vaccine projects, including mass vaccination campaigns using oral cholera vaccine in Mozambique and Zanzibar. Beginning in 2003, Lorenz worked with the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand, on a large multi-center trial to compare the efficacy of parenteral artesunate with parenteral quinine for severe malaria. Beginning in 2006, Lorenz coordinated a trial of the malaria vaccine candidate RTS,S/ASO1 in Tanzania. He is currently coordinator of the Asia Pacific Malaria Elimination Network (APMEN) Vivax Working Group at the Menzies School of Health Research in Darwin, Northern Territory, Australia.